CClinicalTrials.gg
CompletedNCT03925792Updated Mar 11, 2020

Lifestyle Medicine for Enhancing Psychological Wellness in Police Officers

An interventional study of Lifestyle Medicine in Psychological Wellbeing, sponsored by Chinese University of Hong Kong. Completed at 1 site in Hong Kong. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2020-03-11.

Sponsored by Chinese University of Hong Kong · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

This study will examine the feasibility and efficacy of lifestyle medicine for the enhancement of psychological wellness in police officers. The integrative lifestyle intervention is based on the "Healthy Body Healthy Mind (HBHM)" programme developed by the University of Melbourne. It includes lifestyle psychoeducation, physical activity, nutrition and diet, relaxation/ mindfulness, and sleep. These components are weaved with psychological elements such as stress management, cognitive restructuring, motivational interviewing, and goal setting strategies that are led by clinical psychologists. While lifestyle medicine has been recognised for centuries a a mean to improve physical health, the field of lifestyle medicine in the context of mental health is still in its infancy. Nevertheless, there is increasing evidence demonstrating the efficacy of individual components of lifestyle medicine (e.g. diet, physical activities, and sleep) on mood and stress management. With a well-researched lifestyle medicine programme adopted from Australia, the research team of the Chinese University of Hong Kong has customised the intervention protocol to fit the Chinese culture, and has conducted a pilot trial to test the protocol across different communities and work populations. The investigators aim to examine the effectiveness of an integration of multiple lifestyle adjustments on psychological wellness from a holistic body-mind perspective. Acknowledging that police officers are one of hte work populations with stressful work nature, it is in a hope that lifestyle medicine would be effective to facilitate stress coping and enhance the psychological wellness of police officers in the long run.

02

Conditions studied

  • Psychological Wellbeing

Keywords

  • lifestyle Medicine
  • police
  • mood
  • psychological being
  • mental health
  • body-mind
  • resilience
03

In context

Lead sponsor

Chinese University of Hong Kong is the lead sponsor of 1,419 studies on the registry; 487 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  1. Hong Kong residents aged ≥ 18 years;
  2. Cantonese language fluency;
  3. Patient Health Questionnaire (PHQ-9) score ≥ 10; and
  4. Willingness to provide informed consent and comply with the trial protocol.

Exclusion criteria

Exclusion Criteria:

  1. Pregnancy;
  2. Have suicidal ideation with PHQ-9 item 9 score ≥ 2 (referral information to professional services will be provided to those who endorsed items on suicidal ideation);
  3. Using medication or psychotherapy for depression;
  4. Having unsafe conditions and are not recommended for exercising or a change in diet by physicians; and
  5. Have major psychiatric, medical or neurocognitive disorders that make participation infeasible or interfere with the adherence to the lifestyle intervention.
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
40 participants (actual)

Study arms

  • Experimental
    Treatment Group

    Lifestyle Medicine Group 1

    Behavioral: Lifestyle Medicine

  • Experimental
    Waitlist Control Group

    Lifestyle Medicine Group 2

    Behavioral: Lifestyle Medicine

Interventions

  • BehavioralLifestyle Medicine

    diet, sleep, exercise and mindfulness

06

What researchers measure

Primary outcomes

  1. Change in the Patient Health Questionnaire (PHQ-9)

    The PHQ-9, a 20-item questionnaire used for screening, diagnosing, monitoring and measuring the severity of depression, which scores each of the nine DSM-IV criteria as "0" (not at all) to "3" (nearly every day). PHQ-9 scores of 5, 10, 15, and 20 represent mild, moderate, moderately severe and severe depression respectively.

    Time frame: Baseline, 1-week post-treatment and 12-week post treatment

Secondary outcomes

  1. Change in Depression Anxiety Stress Scales (DASS-21)

    DASS-21 is a 21-items scales, comprises three sub-scales which measures the negative emotional states of depression, anxiety, and stress, over the past week. The DASS is based on a dimensional rather than a categorical conception of psychological disorder, thus it has no direct implications for the allocation of patients to discrete diagnostic categories. However, recommended cutoffs for conventional severity labels (normal, moderate, severe) are given in the DASS Manual. Depression Anxiety Stress Normal 0-9 0-7 0-14 Mild 10-13 8-9 15-18 Moderate 14-20 10-14 19-25 Severe 21-27 15-19 26-33 Ex. Severe 28+ 20+ 34+

    Time frame: Baseline, 1-week post-treatment and 12-week post treatment

  2. Change in Insomnia Severity Index (ISI)

    ISI is a 7-item scale designed to evaluate perceived insomnia severity. Ratings on the 5-point Likert scale are obtained on the perceived severity of sleep-onset, sleep-maintenance, early morning awakening problems, satisfaction with current sleep pattern, interference with daily functioning, noticeably of impairment attributed to the sleep problem, and level of distress caused by the sleep problem. Total score categories: 0-7 indicates no clinically significant insomnia, 8-14 refers to subthreshold insomnia,15-21 represents clinical insomnia (moderate severity), and 22-28 is clinical insomnia (severe).

    Time frame: Baseline, 1-week post-treatment and 12-week post treatment

  3. Brief Resilience Scale

    The BRS, originally developed by Smith and colleagues (2008), is a 6-item questionnaire rated on a 5-point Likert scale from 1 (strongly disagree) to 5 (strongly agree). Higher scores represent higher level of psychological resilience. The Chinese version of the test validated by Lai \& Yue (2014) has demonstrated good psychometric properties (Cronbach's alpha \> .72) and were comparable to the original version developed by Smith and colleagues. Total score divided by 6 and to be categorized: 1.00-2.99 indicates low resilience; 3.00-4.30 indicates normal resilience and 4.31-5.00 indicated high resilience.

    Time frame: Baseline, 1-week post-treatment and 12-week post treatment

  4. Short Form (Six-Dimension) Health Survey (SF-6D)

    The SF-6D is a preference-based single index measure of health. A six-digit number represents each SF-6D health state, each digit denotes the level of one of six SF-6D dimensions: physical functioning, role limitation, social functioning, bodily pain, mental health, and vitality. The SF-6D index, scores from 0.0 (worst health state) to 1.0 (best health state).

    Time frame: Baseline, 1-week post-treatment and 12-week post treatment

  5. Health-Promoting Lifestyle Profile (HPLP II)

    The 52-item HPLPII is composed of a total scale and six subscales to measure behaviors in the theorized dimensions of health-promoting lifestyle: spiritual growth, interpersonal relations, nutrition, physical activity, health responsibility, and stress management. Items are scored as Never (N) = 1, Sometimes (S)= 2, Often (O) = 3, Routinely (R) = 4 A score for overall health-promoting lifestyle is obtained by calculating a mean of the individual's responses to all 52 items; six subscale scores are obtained similarly by calculating a mean of the responses to subscale items. The use of means rather than sums of scale items is recommended to retain the 1 to 4 metric of item responses and to allow meaningful comparisons of scores across subscales.

    Time frame: Baseline, 1-week post-treatment and 12-week post treatment

  6. Change in Sheehan Disability Scale (SDS)

    SDS is a brief, 5-item self-report tool that assesses functional impairment in work/school, social life, and family life. Representation of scores in terms of functional impairment: 0: not at all, 1-3: mildly, 4-6: moderately, 7-9: markedly, 10: extremely.

    Time frame: Baseline, 1-week post-treatment and 12-week post treatment

  7. Physical activity (Fitbit Surge Fitness Superwatch)

    The Fitbit Surge, a commercially available accelerometer-based activity tracker, is used to examine patterns of physical activity and heart rate, objectively.

    Time frame: Baseline, 1-week post-treatment and 12-week post treatment

  8. Change in Credibility-Expectancy Questionnaire (CEQ)

    The 6-item CEQ yielded ratings of treatment credibility, acceptability/satisfaction, and expectations for success.

    Time frame: Baseline, 1-week post-treatment

07

Study locations

1 site
  • The Chinese University of Hong Kong
    Hong Kong, Hong Kong
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 11, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT03925792
Lead sponsor
Chinese University of Hong Kong
Collaborators
University of Melbourne, University of Western Sydney
Responsible party
Fiona YY Ho (Assistant Professor, Chinese University of Hong Kong) — Principal investigator
First posted
Apr 24, 2019
Start date
Jun 1, 2019
Primary completion
Nov 30, 2019
Completion
Dec 31, 2019
Last update
Mar 11, 2020

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion